Literature DB >> 15160983

Amebiasis and comparison of microscopy to ELISA technique in detection of Entamoeba histolytica and Entamoeba dispar.

Rose A Nesbitt1, Franklin W Mosha, Hormuzd A Katki, Mohammad Ashraf, Charles Assenga, Clarence M Lee.   

Abstract

The analysis of records of amoebal infection in various hospitals in Kilimanjaro indicated frequent occurrence of amebiasis. The population over the age of five years had higher rate of amoebal infection compared to less than that of a five-year-old population; however, both age groups had similar patterns of amebiasis during January 1999 to June 2001. To investigate misdiagnosis of amebiasis, 226 patients (passive cases) in three hospitals and 616 individuals (active cases) from three different localities in Kilimanjaro were examined. In passive cases, the prevalences of Entamoeba histolytica and Entamoeba dispar were 1% and 7.3%, respectively. Among active cases, 1% were infected with E. histolytica, and 15% were infected with E. dispar. There were no significant differences in amoebal infection between the male and female populations. A pool of 842 stool samples was used for diagnosis of E. histolytica and E. dispar by microscopic examination or ELISA kits. The microscopic examination indicated 8.7% amoebal infection; however, using ELISA as the gold standard, the prevalence of histolytica/dispar was 0.8% and 7.4%, respectively. This study indicated that E. dispar infection was 14.5 times more prevalent than E. histolytica infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160983      PMCID: PMC2640664     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  20 in total

1.  The reliability of Entamoeba histolytica zymodemes in clinical diagnosis.

Authors:  P G Sargeaunt
Journal:  Parasitol Today       Date:  1987-02

2.  The zymodemes of Entamoeba histolytica in New Delhi, India.

Authors:  U K Baveja; S Francis; M Kaur; S K Agarwal
Journal:  J Diarrhoeal Dis Res       Date:  1990 Mar-Jun

3.  Polymerase chain reaction-solution hybridization enzyme-linked immunoassay (PCR-SHELA) for the differential diagnosis of pathogenic and non-pathogenic Entamoeba histolytica.

Authors:  A Aguirre; D C Warhurst; F Guhl; I A Frame
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Mar-Apr       Impact factor: 2.184

4.  Differentiation of pathogenic from nonpathogenic Entamoeba histolytica by restriction fragment analysis of a single gene amplified in vitro.

Authors:  E Tannich; G D Burchard
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

5.  The electrophoretic isoenzyme patterns of strains of Entamoeba histolytica isolated in two major cities in Canada.

Authors:  E M Proctor; Q Wong; J Yang; J S Keystone
Journal:  Am J Trop Med Hyg       Date:  1987-09       Impact factor: 2.345

Review 6.  Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 19 February 1998. Amoebic disease. Entamoeba dispar, an organism reborn.

Authors:  C G Clark
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Jul-Aug       Impact factor: 2.184

7.  A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica.

Authors:  V Gathiram; T F Jackson
Journal:  S Afr Med J       Date:  1987-11-21

8.  Electrophoretic isoenzyme patterns of the pathogenic and non-pathogenic intestinal amoebae of man.

Authors:  P G Sargeaunt; J E Williams
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

9.  Entamoeba histolytica as a commensal intestinal parasite in homosexual men.

Authors:  E Allason-Jones; A Mindel; P Sargeaunt; P Williams
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

Review 10.  A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925.

Authors:  L S Diamond; C G Clark
Journal:  J Eukaryot Microbiol       Date:  1993 May-Jun       Impact factor: 3.346

View more
  8 in total

1.  Development of a salivary IgA detection method for accurate diagnosis of amebiasis.

Authors:  Davin Edric V Adao; Angeline Odelia C Li; Alexander Edward S Dy; Windell L Rivera
Journal:  J Parasit Dis       Date:  2022-04-26

2.  Molecular epidemiology of amebiasis.

Authors:  Ibne Karim M Ali; C Graham Clark; William A Petri
Journal:  Infect Genet Evol       Date:  2008-05-14       Impact factor: 3.342

3.  Prevalence and importance of amebic infestation in patients with ulcerative colitis in two regions in Turkey.

Authors:  Aliye Soylu; Can Dolapcioglu; Halil Alis; Kemal Dolay; Nurgul Yasar; Omer Boduroglu; Aydin Cildas; Fusun F Bolukbas; Cengiz Bolukbas
Journal:  Dig Dis Sci       Date:  2008-09-04       Impact factor: 3.199

4.  Antiamoebic drugs for treating amoebic colitis.

Authors:  Maria Liza M Gonzales; Leonila F Dans; Juliet Sio-Aguilar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-09

5.  Prevalence of parasitic infections and associations with pregnancy complications and outcomes in northern Tanzania: a registry-based cross-sectional study.

Authors:  Aneth Mkunde Mahande; Michael Johnson Mahande
Journal:  BMC Infect Dis       Date:  2016-02-13       Impact factor: 3.090

6.  Comparison of the Triage Micro Parasite Panel and Microscopy for the Detection of Entamoeba histolytica/Entamoeba dispar, Giardia lamblia, and Cryptosporidium parvum in Stool Samples Collected in Kenya.

Authors:  Brett Swierczewski; Elizabeth Odundo; Janet Ndonye; Ronald Kirera; Cliff Odhiambo; Edwin Oaks
Journal:  J Trop Med       Date:  2012-07-10

7.  Prevalence of Cryptosporidium parvum/hominis, Entamoeba histolytica and Giardia lamblia among Young Children with and without Diarrhea in Dar es Salaam, Tanzania.

Authors:  Marit G Tellevik; Sabrina J Moyo; Bjørn Blomberg; Torunn Hjøllo; Samuel Y Maselle; Nina Langeland; Kurt Hanevik
Journal:  PLoS Negl Trop Dis       Date:  2015-10-09

8.  Prevalence of Entamoeba histolytica/Entamoeba dispar in the city of Campina Grande, in northeastern Brazil.

Authors:  Maria Teresa Nascimento Silva; José Valfrido Santana; Gérson Bragagnoli; Alexandre Magno da Nóbrega Marinho; Elizabeth Malagueño
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Sep-Oct       Impact factor: 1.846

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.